ClearPoint Neuro, Inc. (CLPT) stock
CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3021% above fair value
$8.48−0.01 (-0.12%)
Close on Nov 13, 2026Market cap $271.82MP/E –Yield –
ClearPoint Neuro profit margin
Profit margin (net margin) is net income as a percentage of revenue.
ClearPoint Neuro's profit margin for the twelve months ending Sep 30, 2026 was -79.4%. For fiscal 2025 it was -69.1%, against -60.3% the year before. The highest annual figure on record is -49.4% in fiscal 2019.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -69.1% | −8.8 |
| FY2024 | Dec 31, 2024 | -60.3% | +32.0 |
| FY2023 | Dec 31, 2023 | -92.2% | −12.2 |
| FY2022 | Dec 31, 2022 | -80.0% | +8.4 |
| FY2021 | Dec 31, 2021 | -88.4% | −35.5 |
| FY2020 | Dec 31, 2020 | -52.9% | −3.5 |
| FY2019 | Dec 31, 2019 | -49.4% | +34.4 |
| FY2018 | Dec 31, 2018 | -83.8% | +13.3 |
| FY2017 | Dec 31, 2017 | -97.1% | +43.2 |
| FY2016 | Dec 31, 2016 | -140.4% | +43.6 |
| FY2015 | Dec 31, 2015 | -183.9% | −58.4 |
| FY2014 | Dec 31, 2014 | -125.5% | +54.8 |
| FY2013 | Dec 31, 2013 | -180.3% | −64.1 |
| FY2012 | Dec 31, 2012 | -116.2% | +101.5 |
| FY2011 | Dec 31, 2011 | -217.7% | +136.5 |
| FY2010 | Dec 31, 2010 | -354.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -61.8% | +4.7 |
| Q2 FY2026 | Jun 30, 2026 | -104.2% | −40.9 |
| Q1 FY2026 | Mar 31, 2026 | -78.8% | −7.7 |
| Q4 FY2025 | Dec 31, 2025 | -74.8% | −5.5 |
| Q3 FY2025 | Sep 30, 2025 | -66.5% | −5.2 |
| Q2 FY2025 | Jun 30, 2025 | -63.3% | −7.2 |
| Q1 FY2025 | Mar 31, 2025 | -71.0% | −16.7 |
| Q4 FY2024 | Dec 31, 2024 | -69.3% | −1.5 |
| Q3 FY2024 | Sep 30, 2024 | -61.2% | +22.2 |
| Q2 FY2024 | Jun 30, 2024 | -56.1% | +62.4 |
| Q1 FY2024 | Mar 31, 2024 | -54.3% | +49.0 |
| Q4 FY2023 | Dec 31, 2023 | -67.8% | +16.9 |
| Q3 FY2023 | Sep 30, 2023 | -83.5% | −9.9 |
| Q2 FY2023 | Jun 30, 2023 | -118.5% | −35.8 |
| Q1 FY2023 | Mar 31, 2023 | -103.2% | −24.5 |
| Q4 FY2022 | Dec 31, 2022 | -84.8% | +12.1 |
| Q3 FY2022 | Sep 30, 2022 | -73.6% | +13.4 |
| Q2 FY2022 | Jun 30, 2022 | -82.8% | +26.9 |
| Q1 FY2022 | Mar 31, 2022 | -78.7% | −15.7 |
| Q4 FY2021 | Dec 31, 2021 | -96.9% | −54.3 |
| Q3 FY2021 | Sep 30, 2021 | -87.0% | −44.8 |
| Q2 FY2021 | Jun 30, 2021 | -109.7% | −42.6 |
| Q1 FY2021 | Mar 31, 2021 | -63.0% | +3.0 |
| Q4 FY2020 | Dec 31, 2020 | -42.6% | +8.7 |
| Q3 FY2020 | Sep 30, 2020 | -42.2% | −3.8 |
| Q2 FY2020 | Jun 30, 2020 | -67.0% | −7.5 |
| Q1 FY2020 | Mar 31, 2020 | -65.9% | −16.6 |
| Q4 FY2019 | Dec 31, 2019 | -51.3% | +2.2 |
| Q3 FY2019 | Sep 30, 2019 | -38.4% | +40.7 |
| Q2 FY2019 | Jun 30, 2019 | -59.5% | +54.5 |
| Q1 FY2019 | Mar 31, 2019 | -49.4% | +51.7 |
| Q4 FY2018 | Dec 31, 2018 | -53.5% | +70.5 |
| Q3 FY2018 | Sep 30, 2018 | -79.0% | +4.0 |
| Q2 FY2018 | Jun 30, 2018 | -114.0% | −12.5 |
| Q1 FY2018 | Mar 31, 2018 | -101.1% | −18.6 |
| Q4 FY2017 | Dec 31, 2017 | -124.0% | −21.2 |
| Q3 FY2017 | Sep 30, 2017 | -83.0% | – |
| Q2 FY2017 | Jun 30, 2017 | -101.4% | – |
| Q1 FY2017 | Mar 31, 2017 | -82.5% | – |
| Q4 FY2016 | Dec 31, 2016 | -102.8% | – |
See a number that looks wrong?